During embryogenesis, endothelial cells induce organogenesis before the development of circulation 1-4 . These findings suggest that endothelial cells not only form passive conduits to deliver nutrients and oxygen, but also establish an instructive vascular niche, which through elaboration of paracrine trophogens stimulates organ regeneration, in a manner similar to endothelialcell-derived angiocrine factors that support haematopoiesis 5-7 . However, the precise mechanism by which tissue-specific subsets of endothelial cells promote organogenesis in adults is unknown. Here we demonstrate that liver sinusoidal endothelial cells (LSECs) constitute a unique population of phenotypically and functionally defined VEGFR3 1 CD34 2 VEGFR2 1 VE-cadherin 1 FactorVIII 1 CD45 2 endothelial cells, which through the release of angiocrine trophogens initiate and sustain liver regeneration induced by 70% partial hepatectomy. After partial hepatectomy, residual liver vasculature remains intact without experiencing hypoxia or structural damage, which allows study of physiological liver regeneration. Using this model, we show that inducible genetic ablation of vascular endothelial growth factor (VEGF)-A receptor-2 (VEGFR2) in the LSECs impairs the initial burst of hepatocyte proliferation (days 1-3 after partial hepatectomy) and subsequent reconstitution of the hepatovascular mass (days 4-8 after partial hepatectomy) by inhibiting upregulation of the endothelial-cell-specific transcription factor Id1. Accordingly, Id1-deficient mice also manifest defects throughout liver regeneration, owing to diminished expression of LSEC-derived angiocrine factors, including hepatocyte growth factor (HGF) and Wnt2. Notably, in in vitro co-cultures, VEGFR2-Id1 activation in LSECs stimulates hepatocyte proliferation. Indeed, intrasplenic transplantation of Id1 1/1 or Id1 2/2 LSECs transduced with Wnt2 and HGF (Id1 2/2 Wnt2 1 HGF 1 LSECs) re-establishes an inductive vascular niche in the liver sinusoids of the Id1 2/2 mice, initiating and restoring hepatovascular regeneration. Therefore, in the early phases of physiological liver regeneration, VEGFR2-Id1-mediated inductive angiogenesis in LSECs through release of angiocrine factors Wnt2 and HGF provokes hepatic proliferation. Subsequently, VEGFR2-Id1-dependent proliferative angiogenesis reconstitutes liver mass. Therapeutic cotransplantation of inductive VEGFR2 1 Id1 1 Wnt2 1 HGF 1 LSECs with hepatocytes provides an effective strategy to achieve durable liver regeneration.
During embryogenesis, endothelial cells induce organogenesis before the development of circulation [1] [2] [3] [4] . These findings suggest that endothelial cells not only form passive conduits to deliver nutrients and oxygen, but also establish an instructive vascular niche, which through elaboration of paracrine trophogens stimulates organ regeneration, in a manner similar to endothelialcell-derived angiocrine factors that support haematopoiesis [5] [6] [7] . However, the precise mechanism by which tissue-specific subsets of endothelial cells promote organogenesis in adults is unknown. Here we demonstrate that liver sinusoidal endothelial cells (LSECs) constitute a unique population of phenotypically and functionally defined VEGFR3 1 CD34 2 VEGFR2 1 VE-cadherin 1 FactorVIII 1 CD45 2 endothelial cells, which through the release of angiocrine trophogens initiate and sustain liver regeneration induced by 70% partial hepatectomy. After partial hepatectomy, residual liver vasculature remains intact without experiencing hypoxia or structural damage, which allows study of physiological liver regeneration. Using this model, we show that inducible genetic ablation of vascular endothelial growth factor (VEGF)-A receptor-2 (VEGFR2) in the LSECs impairs the initial burst of hepatocyte proliferation (days 1-3 after partial hepatectomy) and subsequent reconstitution of the hepatovascular mass (days 4-8 after partial hepatectomy) by inhibiting upregulation of the endothelial-cell-specific transcription factor Id1. Accordingly, Id1-deficient mice also manifest defects throughout liver regeneration, owing to diminished expression of LSEC-derived angiocrine factors, including hepatocyte growth factor (HGF) and Wnt2. Notably, in in vitro co-cultures, VEGFR2-Id1 activation in LSECs stimulates hepatocyte proliferation. Indeed, intrasplenic transplantation of Id1 1/1 or Id1 2/2 LSECs transduced with Wnt2 and HGF (Id1 2/2 Wnt2 1 HGF 1 LSECs) re-establishes an inductive vascular niche in the liver sinusoids of the Id1 2/2 mice, initiating and restoring hepatovascular regeneration. Therefore, in the early phases of physiological liver regeneration, VEGFR2-Id1-mediated inductive angiogenesis in LSECs through release of angiocrine factors Wnt2 and HGF provokes hepatic proliferation. Subsequently, VEGFR2-Id1-dependent proliferative angiogenesis reconstitutes liver mass. Therapeutic cotransplantation of inductive VEGFR2 1 Id1 1 Wnt2 1 HGF 1 LSECs with hepatocytes provides an effective strategy to achieve durable liver regeneration.
Sinusoidal endothelial cells (SECs) compose a structurally and functionally unique capillary network that vascularizes specific organs, including bone marrow and liver. In adult mice, bone marrow SECs, through expression of specific angiocrine trophogens, such as Notch ligands, support haematopoietic regeneration [5] [6] [7] . Similarly, the hepatic circulation is predominantly lined by LSECs 8-10 , with each hepatocyte residing in cellular proximity to LSECs. However, the lack of phenotypic and operational definition of liver endothelial cells and paucity of relevant mouse angiogenic genetic models [11] [12] [13] have handicapped studies of the role of LSECs in regulation of hepatic regeneration [14] [15] [16] [17] [18] .
Here, we use a physiologically relevant partial hepatectomy model to elucidate the instructive role of LSECs in mediating hepatic regeneration ( Supplementary Fig. 1 ). In contrast to the administration of hepatotoxic chemicals, which impairs the organization of LSECs and causes tissue hypoxia, cell death and inflammation ( Supplementary Fig. 2) 8, 13, 19 , in the partial hepatectomy model, resection of 70% of the liver mass without perturbing the integrity of the residual liver vasculature 11 activates hepatocyte regeneration [15] [16] [17] . As such, this model provides an instructive model for interrogating the role of structurally and functionally intact LSECs in supporting liver regeneration.
As the VEGF family plays a critical role in the regeneration of the bone marrow SECs 6 , we hypothesized that VEGF receptors [20] [21] [22] , including VEGFR2 or VEGFR3, also modulate LSEC function. Using VEGFR2-GFP mice in which the expression of green fluorescent protein (GFP) is driven by the native promoter of VEGFR2, we demonstrate that VEGFR2 and VEGFR3 are exclusively expressed in the liver endothelial cells but not in other liver cell types, including hepatocyte nuclear factor 4a (HNF4A) 1 hepatocytes ( Fig. 1a and Supplementary Fig. 3 ). Notably, distribution of VEGFR3 expression is restricted to VEGFR2 1 LSECs that branch out from CD34 1 VEGFR3 2 large vessels ( Fig. 1b ). Polyvariate flow cytometric analysis on nonparenchymal cells (NPCs) demonstrates the expression of endothelialspecific marker VE-cadherin on non-haematopoietic VEGFR3 1 VEGFR2 1 CD45 2 LSECs, 97.6% of which are non-lymphatic (Prox1 2 CD34 2 ) 22 endothelial cells expressing coagulation factor VIII ( Fig. 1c, d ). Thus we have designated a unique phenotypic and operational signature for LSECs of adult mice as VEGFR3 1 CD34 2 VEGFR2 1 VE-cadherin 1 FactorVIII 1 Prox-1 2 CD45 2 vessels, distinguishing them from VEGFR3 2 CD34 1 VEGFR2 1 VE-cadherin 1 CD45 2 non-sinusoidal endothelial cells and VEGFR3 1 CD34 1 Prox-1 1 FactorVIII 2 CD45 2 lymphatic endothelial cells. Identification of LSECs as VEGFR3 1 CD34 2 and non-sinusoidal endothelial cells as VEGFR3 2 CD34 1 is sufficient for quantification, purification and molecular profiling of LSECs.
To determine the mechanism by which LSECs regulate hepatic proliferation, we studied the regenerative kinetics of hepatocytes and LSECs after partial hepatectomy. Two days after partial hepatectomy, staining with VE-cadherin, hepatocyte marker epithelial (E)-cadherin and mitotic marker phosphorylated-histone-3 (P-H3) revealed that P-H3 1 E-cadherin 1 mitotic hepatocytes were positioned in the proximity of non-proliferating LSECs (Fig. 1e ). However, proliferation of LSECs starts at day 4 and plateaus by day 8 after partial hepatectomy ( Fig. 1f and Supplementary Fig. 4 ). In comparison, quantification of P-H3 1 HNF4A 1 hepatocytes showed that the rate of hepatocyte proliferation peaks during the first 4 days, levelling off by day 8 (Fig. 1g) . These results suggest a chronologically biphasic contribution of LSECs in mediating hepatic reconstitution. At the early phases of partial hepatectomy (days 1-3 after partial hepatectomy), inductive angiogenesis in the non-proliferative LSECs stimulates hepatic regeneration, possibly by releasing angiocrine factors, whereas 4 days after partial hepatectomy, the increased demand of blood supply for the regenerating liver is met by proliferative angiogenesis of LSECs.
To investigate the significance of VEGF receptors during LSECdriven hepatic regeneration, we designed experiments to delete the VEGFR2 gene conditionally by crossing VEGFR2 loxP/loxP mice with ROSA-CreER T2 mice, generating inducible VEGFR2-deficient, VEGFR2 flox/flox (VEGFR2 fl/fl ) mice ( Supplementary Fig. 5 ) 6 . Owing to the endothelial-cell-specific expression of VEGFR2 in the liver, in VEGFR2 fl/fl mice only liver endothelial cells, but not non-endothelial cells, will manifest functional defects. As control, we used mice with heterozygous deletion of the VEGFR2 gene (VEGFR2 fl/1 ). Forty-eight hours after partial hepatectomy, bromodeoxyuridine 1 hepatocyte proliferation (BrdU 1 HNF4A 1 cell number) was decreased by 67% in VEGFR2 fl/fl mice ( Fig. 2a, b) . Notably, despite the patency of the VE-cadherin 1 isolectin 1 perfused vessels at this early phase, the regeneration of liver mass was attenuated in VEGFR2 fl/fl mice ( Fig. 2c ). Therefore, in the early phases (partial hepatectomy days 1-3) of the liver regeneration, targeting VEGFR2 primarily impairs the effect of endothelial-derived angiocrine factors to induce hepatocyte regeneration, but not vascular perfusion capacity.
However, in VEGFR2 fl/fl mice at the later stages of liver regeneration (partial hepatectomy days 4-8), proliferative angiogenesis was also defective ( Fig. 2c) , interfering with the assembly of patent VEcadherin 1 isolectin 1 vasculature ( Fig. 2d, e ), thereby blunting restoration of the liver mass for at least 28 days ( Supplementary Fig. 5 ). Furthermore, in VEGFR2 fl/fl mice, liver function after partial hepatectomy was abnormal, as manifested by elevated plasma bilirubin levels. To corroborate the endothelial-specific VEGFR2 function in mediating liver regeneration, VEGFR2 loxP/loxP mice were also crossed with VE-cadherin-CreER T2 mice to induce endothelial-selective deletion of VEGFR2 ( Supplementary Fig. 5 ). Both the liver mass and formation of perfused vessels in the VE-cadherin-CreER T2 VEGFR2 fl/fl Normal liver liver regeneration induced by 70% partial hepatectomy (PH). a, Liver sections obtained from VEGFR2-GFP reporter mice 6 . During liver regeneration VEGFR2 is exclusively expressed on the liver endothelial cells. b, Restricted expression of VEGFR3 on LSECs, but not CD34 1 large vessels or hepatocytes. c, Polyvariate flow cytometric analysis of the liver nonparenchymal cells. VEGFR2 1 cells that are CD45 2 , express endothelial-specific VE-cadherin. d, Specific expression of VEGFR3 on VEGFR2 1 VE-cadherin 1 CD45 2 LSECs, with a predominant fraction being CD34 2 FactorVIII 1 Prox-1 2 . Thus LSECs could be identified as VEGFR3 1 CD34 2 cells. e, Forty-eight hours after partial hepatectomy, E-cadherin 1 P-H3 1 mitotic hepatocytes are localized adjacent to VEcadherin 1 and VEGFR2 1 endothelial cells. f, g, Kinetics of LSEC expansion (f) and hepatocyte mitosis (g) during liver regeneration (n 5 4); hpf, highpower field. Scale bars, 50 mm. Error bars, s.e.m.
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mice were decreased after partial hepatectomy, which emphasizes the significance of VEGFR2 in mediating liver regeneration. Indeed, if the VEGF-A/VEGFR2 pathway promotes the LSEC-driven hepatic regeneration, then VEGF-A should enhance liver regeneration. Hence we compared the effect of VEGF-A 164 with placental growth factor (PlGF), as the latter selectively activates only VEGFR1 21 . After partial hepatectomy, VEGF 164 , but not PlGF, accelerated the regeneration of both liver mass and the number of VEGFR3 1 CD34 2 LSECs, which were sustained for at least 28 days ( Fig. 2f, g) . Therefore, after partial hepatectomy, the activation of VEGF-A/VEGFR2, but not PlGF/ VEGFR1, is crucial for priming LSECs to initiate and maintain hepatic proliferation.
To identify the angiocrine signals that stimulate liver regeneration, we used microarray analysis ( Supplementary Fig. 6 and Supplementary Table 1 ). Among the endothelial-specific genes, the transcription factor Id1 was specifically upregulated in the endothelial cells activated by partial hepatectomy 23 . Using Id1 venusYFP reporter mice in which the venusYFP expression is driven by the Id1 promoter 24 , we found exclusive Id1 upregulation in LSECs 48 h after partial hepatectomy ( Fig. 2h ), which was significantly blunted in VEGFR2 fl/fl mice (Fig. 2i ). Remarkably, the liver mass recovery in Id1-deficient (Id1 2/2 ) mice after partial hepatectomy was impaired for 28 days and remained unchanged upon VEGF-A 164 administration ( Fig. 3a and Supplementary Fig. 7 ). Furthermore, after partial hepatectomy, Id1 2/2 mice exhibited significant decrease in mitotic BrdU 1 HNF4A 1 hepatocyte number, disrupted formation of functional VE-cadherin 1 isolectin 1 vessels, diminished proliferation of VEGFR3 1 CD34 2 LSECs, and abnormal liver function, as evidenced by an increase in plasma bilirubin levels (Fig. 3b, c and Supplementary Fig. 7 ). Thus activation of the VEGF-A/VEGFR2 pathway through upregulation of Id1 drives liver regeneration.
The role of Id1 upregulation in mediating the angiocrine function of LSECs on hepatocyte proliferation was also examined by an LSEChepatocyte co-culture system. Co-incubation of isolated hepatocytes with primary LSECs led to a ninefold increase in hepatocyte number, which was selectively abolished by knockdown of Id1 in LSECs (Fig. 3d, e and Supplementary Fig. 8 ). Conditioned medium from LSECs failed to support hepatocyte growth, underlining the importance of cell-cell contact in LSEC-derived angiocrine function. Therefore lack of Id1 results in defective inductive function of LSECs, impairing hepatocyte regeneration.
To determine whether in vivo angiocrine effects of Id1 1/1 LSECs could initiate hepatocyte regeneration in Id1 2/2 mice, we used the intrasplenic transplantation approach on day 2 after partial hepatectomy to engraft LSECs into the Id1 2/2 liver vasculature (Fig. 3f) 25 . 
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GFP-marked Id1 1/1 LSECs selectively incorporated into the VEGFR3 1 sinusoidal vascular lumen and restored the regeneration of liver mass and LSEC expansion ( Fig. 3g and Supplementary Fig. 9 ). In contrast, the transplanted Id1 2/2 LSECs failed to restore the regeneration of the Id1 2/2 liver. Moreover, in the Id1 2/2 liver, transplantation of GFP 1 Id1 1/1 LSECs at day 2 after partial hepatectomy initiated the proliferation of the hepatocytes in their immediate proximity (Fig. 3h, i) . Thus partial vascular chimaerism afforded by the incorporation of Id1-competent LSECs generates sufficient endothelial-cellderived inductive signals to initiate hepatic proliferation in the Id1 2/2 liver.
To identify endothelial-derived angiocrine factors that induce liver regeneration, we analysed LSECs purified from the wild-type and Id1 2/2 mice 48 h after partial hepatectomy. Among the known hepatic trophogens 10,18,26-28 , the expression of Wnt2 and HGF, but not other trophogens expressed by LSECs, such as Wnt9B and thrombomodulin, were drastically diminished in Id1 2/2 LSECs ( Fig. 4a and Supplementary Fig. 10 ). These results suggest that Id1 upregulation in LSECs initiates hepatocyte proliferation through inducing Wnt2 and HGF expression. To test this hypothesis, on day 2 after partial hepatectomy, we engrafted Id1 2/2 LSECs transduced with Wnt2, HGF or both into the Id1 2/2 liver vasculature by intrasplenic transplantation. Only Id1 2/2 LSECs carrying both Wnt2 and HGF (Id1 2/2 Wnt2 1 HGF 1 ) restored the regeneration of mass and LSEC expansion in the Id1 2/2 liver (Fig. 4b) , which suggests a collaborative effect between HGF and Wnt2. Notably, transplantation of Id1 2/2 Wnt2 1 HGF 1 LSECs into Id1 2/2 mice increased the mitotic BrdU 1 HNF4A 1 hepatocyte number to a similar degree achieved by Id1 1/1 LSEC transplantation (Fig. 4c ). The mitotic hepatocytes were also found to be positioned adjacent to the transplanted Id1 2/2 Wnt2 1 HGF 1 GFP 1 LSECs (Fig. 4d ). Therefore Id1-activated LSECs through elaboration of Wnt2 and HGF induce proliferation of juxtaposed hepatocytes (Fig. 4e ).
Here we have used conditional VEGFR2 knockout, Id1 2/2 mice, and an endothelial cell transplantation model to identify the essential angiocrine role of a specialized organ-specific vascular niche cell, defined operationally as VEGFR3 1 CD34 2 VEGFR2 1 VE-cadherin 1 FactorVIII 1 Prox1 2 CD45 2 LSECs, in orchestrating physiological liver regeneration 
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induced by partial hepatectomy. Similar to upregulation of Id1 in the angiogenic tumour vessels 23 , Id1 expression is minimal in the normal LSECs, but after partial hepatectomy activation of VEGFR2 induces exclusive upregulation of Id1 in the angiogenic LSECs. We demonstrate that in the first 3 days after partial hepatectomy, activation of the VEGFR2-Id1 pathway switches on an inductive angiogenesis program in non-proliferative VEGFR3 1 CD34 2 VEGFR2 1 Id1 1 LSECs, which, through production of angiocrine factors Wnt2 and HGF, provokes hepatic proliferation. Subsequently, as the regenerating liver demands additional blood supply, VEGFR2-Id1-mediated proliferative angiogenesis of LSECs reconstitutes hepatovascular mass. Therefore, we introduce the concept that LSECs support liver regeneration through a biphasic mechanism: at the early phase immediately after partial hepatectomy, inductive angiogenic LSECs promote organogenesis through release of angiocrine factors, whereas proliferative angiogenic LSECs vascularize and sustain the expanding liver mass. We show that transplantation of the Id1 2/2 Wnt2 1 HGF 1 LSECs into Id1 2/2 mice initiates and restores liver regeneration. This finding, and the observation that hepatic proliferation is severely blunted in the VEGFR2 and Id1-deficient mice, suggest that LSECs are chartered with the responsibility of establishing an inductive vascular niche to initiate hepatic proliferation by elaborating angiocrine factors. Because isolation of LSECs for therapeutic liver regeneration might encounter technical difficulties, endothelial progenitor cells (EPCs) derived from non-hepatic tissues may alternatively substitute for LSECs to initiate and restore liver regeneration 29 . Notably, VEGFR2 1 Id1 1 EPCs could initiate angiogenesis through release of angiocrine factors rather than structurally incorporating into vessel wall 29 . As such, intrahepatic transplantation of EPCs will open up new avenues of cell therapy to promote liver regeneration.
In the partial hepatectomy model used in our study, the vascular integrity of the residual liver lobes is maintained with minimal inflammatory response ( Supplementary Fig. 2) , thereby establishing an ideal model to study endothelial-dependent liver regeneration. However, in chemical (CCl 4 )-induced liver injury models, severe vascular damage and cell death might require the recruitment of other non-endothelial cells, including stellate cells 19 and pro-angiogenic haematopoietic cells, such as CXCR4 1 VEGFR1 1 hemangiocytes 30 , to support liver regeneration.
However, here is one unsolved enigma: how is removal of 70% of the liver sensed by the LSECs in the residual liver to ignite hepatic proliferation [14] [15] [16] [17] ? Conceivably, the mass of the liver is maintained through continuous release of as yet unrecognized inhibitory factors. Removal of the liver shifts the balance towards the predominance of vascular excitatory factors, which activate LSECs. Likewise, an increase in the mass of the liver 4 days after partial hepatectomy instigates the release of factors that stimulate sprouting angiogenesis in LSECs. Subsequently, recovery of the liver to its developmentally predetermined baseline mass might re-establish as yet unidentified inhibitory signals that terminate the regenerative process. The rapid regeneration of the liver after partial hepatectomy requires collective and global proliferation of many hepatocytes. Indeed, as each hepatocyte resides in close proximity to LSECs, this remarkably harmonious activation of hepatocytes is achieved by switching on an angiocrine-dependent regenerative program to induce proliferation of mature hepatocytes throughout the residual liver after partial hepatectomy. Whether angiocrine factors could also promote the propagation of liver progenitor cells 14 , in addition to the mature hepatocytes, remains to be investigated.
In our study, Wnt2 and HGF represent the predominant liverspecific angiocrine factors driving hepatic regeneration. As direct cellular contact between LSECs and hepatocytes was essential for proliferation of hepatocytes, it is conceivable that other angiocrine factors might collaborate with Wnt2 and HGF to modulate liver regeneration. For instance, endothelial-specific extracellular matrix components, proteases, adhesion molecules and chemokines might also participate in hepatogenesis. Our in vitro endothelial cell-hepatocyte co-culture model and in vivo intrasplenic transplantation model provide ideal models to assess the role of these unknown angiocrine factors in modulating hepatic homeostasis during recovery from chemical or traumatic injury.
Accumulating evidence suggests that, in addition to LSECs, other organ-specific vascular niches play a seminal role in organ repair and tumorigenesis [5] [6] [7] . For example, stress-induced expression of Notch ligands by the bone marrow SECs has been shown to be essential for haematopoietic stem cell reconstitution 5 . Furthermore, elaboration of specific prototypical angiocrine factors, such as BMP2, nitric oxide, FGF2 and PDGF-b, by tumour vessels also directly provokes tumour progression and metastasis 7 . Collectively, these data suggest that tissue-specific expression of defined angiocrine factors may dictate heterogeneity of vasculature in regulating developmental and adult organogenesis.
So far, attempts at liver regeneration by hepatocyte transplantation have culminated in limited success 25 . Our study indicates that cotransplantation of hepatocytes or their progenitor cells 14 
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physiological liver regeneration is dependent on the proper inductive and proliferative functioning of the LSECs also calls for the assessment of the potential increased risks of anti-angiogenic therapy in clinical trials involving liver regeneration.
METHODS SUMMARY
Transgenic reporter, gene targeted animals and mouse surgery. C57BL/6J mice were obtained from Jackson Laboratories. VEGFR2-GFP mice were acquired from J. Rossant. VE-cadherin-CreER T2 mice were provided by L. Iruela-Arispa. Inducible VEGFR2 knockout (generated by T. N. Sato) and Id1 2/2 mice were previously described 6, 23 . Id1 venusYFP mice were obtained from R. Benezra 24 . Partial hepatectomy was performed by resecting three most anterior lobes. Hepatic engraftment of endothelial cells was adapted as previously reported 25 . All animal experiments were performed under the guidelines set by the Institutional Animal Care and Use Committee. Image acquisition, image analysis, and flow cytometric analysis. Fluorescent images were captured on AxioVert LSM510 or 710 confocal microscope (Zeiss). For flow cytometry, antibodies were conjugated to Alexa Fluorescent dyes or Qdots (Invitrogen). Purified liver cells were analysed on LSRII-SORP (BD Biosciences). Doublets were excluded by FSC-W 3 FSC-H and SSC-W 3 SSC-H analysis, and single-stained channels were used for compensation.
procedure was modified from that previously described 25 . Briefly, 48 h after partial hepatectomy, Id1 2/2 mice were anaesthetized and placed in the right lateral decubitus position. The left flank was scrubbed with Betadine, and the skin and abdominal wall were incised longitudinally (parallel to the spine). After the spleen was exteriorized, Id1 1/1 regenerative LSECs were injected into the parenchyma of the spleen through a 27-gauge needle. A splenectomy was performed after the injection. To compare the rescuing effect of Id1 1/1 regenerative LSECs, Id1 2/2 and wild-type mice also subjected to the intrasplenic injection of PBS and splenectomy 2 days after partial hepatectomy (sham transplant). To introduce Wnt2 and HGF expression in LSECs, Wnt2 and HGF complementary DNAs were purchased from Open Biosystems and cloned into lentiviral vector as described above. Infection of LSECs with virus encoding Wnt2 or HGF, or the same amounts of mixed Wnt2 and HGF, was performed with GFP lentivirus infection. Data analysis. All data are presented as the mean 6 s.e.m. of at least three separate experiments. Differences between groups were tested for statistical significance using Student's t-test or analysis of variance. Statistical significance was set at P , 0.05.
